96
Views
13
CrossRef citations to date
0
Altmetric
Review

Novel therapies for osteoporosis

Pages 611-621 | Published online: 02 Mar 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Diane M Biskobing. (2007) Update on bazedoxifene: A novel selective estrogen receptor modulator. Clinical Interventions in Aging 2:3, pages 299-303.
Read now
Pierre Close, Audrey Neuprez & Jean-Yves Reginster. (2006) Developments in the pharmacotherapeutic management of osteoporosis. Expert Opinion on Pharmacotherapy 7:12, pages 1603-1615.
Read now
Robert L Ohsfeldt. (2004) Estimating the cost effectiveness of alternative drug treatments for postmenopausal osteoporosis. Expert Review of Pharmacoeconomics & Outcomes Research 4:6, pages 637-644.
Read now
. (2004) Methylenedioxyanilino-quinazolines and -cyanoquinolines as inhibitors of MEK and/or Src. Expert Opinion on Therapeutic Patents 14:7, pages 1095-1100.
Read now

Articles from other publishers (9)

Ju Eun Je, Sang Jung Ahn, Na Young Kim, Jung Soo Seo, Moo-Sang Kim, Nam Gyu Park, Joong Kyun Kim, Joon Ki Chung & Hyung Ho Lee. (2009) Molecular cloning, expression analysis and enzymatic characterization of cathepsin K from olive flounder (Paralichthys olivaceus). Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 154:4, pages 474-485.
Crossref
Adolfo Diez-Perez. (2006) Selective estrogen receptor modulators (SERMS). Arquivos Brasileiros de Endocrinologia & Metabologia 50:4, pages 720-734.
Crossref
Ian R. Baird, Renee Mosi, Micki Olsen, Beth R. Cameron, Simon P. Fricker & Renato T. Skerlj. (2006) ‘3+1’ mixed-ligand oxorhenium(V) complexes and their inhibition of the cysteine proteases cathepsin B and cathepsin K. Inorganica Chimica Acta 359:9, pages 2736-2750.
Crossref
David W. Dempster & Michael A. Bolognese. (2006) Ibandronate: The Evolution of a Once-a-Month Oral Therapy for Postmenopausal Osteoporosis. Journal of Clinical Densitometry 9:1, pages 58-65.
Crossref
Adolfo Díez-Pérez & José Luis Dueñas-Díez. 2006. Selective Estrogen Receptor Modulators. Selective Estrogen Receptor Modulators 187 206 .
Liqin Zhao, Kathleen O’Neill & Roberta Diaz Brinton. (2005) Selective estrogen receptor modulators (SERMs) for the brain: Current status and remaining challenges for developing NeuroSERMs. Brain Research Reviews 49:3, pages 472-493.
Crossref
Gerold Holzer, Helge Noske, Thomas Lang, Lukas Holzer & Ulrike Willinger. (2005) Soluble cathepsin K: A novel marker for the prediction of nontraumatic fractures?. Journal of Laboratory and Clinical Medicine 146:1, pages 13-17.
Crossref
Iratxe Ciriza, Paloma Carrero, Iñigo Azcoitia, Scott G. Lundeen & Luis M. Garcia‐Segura. (2004) Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: Differences with the effect of estradiol. Journal of Neurobiology 61:2, pages 209-221.
Crossref
George D. Hartman & Robert S. Meissner. 2004. 67 78 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.